2. Signaling Pathways
  3. Anti-infection
  4. Bacterial

Bacterial

Bacterial

Related Products

PDF 14.26 MB

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N14170
    Ashimycin B
    		Inhibitor
    Ashimycin B is a Streptomycin (HY-B1906) analogue with a broad-spectrum antibacterial activity.
    Ashimycin B
  • HY-101967
    GSK299423
    		Inhibitor
    GSK 299423 is an antibiotic agent.GSK299423 shows potent inhibition of supercoiling by DNA gyrase from S. aureus(IC50=14 nM）and Escherichia coli(IC50=100 nM.
    GSK299423
  • HY-169697
    Thiocillin
    		Inhibitor
    Thiocillin is a thiopeptide class of RiPPs and anti-bacterial agent. Thiocillin targets the bacterial 50S ribosome. Thiocillin exhibits potent antibacterial activity against a number of agent resistant pathogens.
    Thiocillin
  • HY-N14209
    Epithienamycin D
    		Inhibitor
    Epithienamycin D is a carbapenem antibiotic. Epithienamycin D has anti-Gram-positive bacteria and anti-Gram-negative bacteria activity.
    Epithienamycin D
  • HY-B1241R
    Dihydrostreptomycin sulfate (Standard)
    		Inhibitor
    Dihydrostreptomycin (sulfate) (Standard) is the analytical standard of Dihydrostreptomycin (sulfate) (HY-B1241). This product is intended for research and analytical applications. Dihydrostreptomycin sulfate (DHSM sulfate) is the sulfate salt form of Dihydrostreptomycin (HY-B1241A). Dihydrostreptomycin sulfate is an aminoglycoside antibiotic with antibacterial effect against Gram-negative bacteria. Dihydrostreptomycin sulfate exhibits ototoxicity that causes irreversible damage in inner ear hair cells, leading to hearing loss.
    Dihydrostreptomycin sulfate (Standard)
  • HY-N12232
    Carbazomycin D
    		Inhibitor
    Carbazomycin D exhibits antituberculosis and antimalarial activities, that inhibits Plasmodium falciparum with an IC50 > 10 μg/mL, inhibits Mycobacterium tuberculosis with MIC of 25 μg/mL. Carbazomycin D exhibits cytotoxicity in cell MCF-7, KB, NCI-H187 and Vero, with IC50s of 21.3, 33.2, 12.9, and 34.3 μg/mL, respectively.
    Carbazomycin D
  • HY-N14797
    Macquarimicin A
    		Inhibitor
    Macquarimicin A is an antibiotic.
    Macquarimicin A
  • HY-123914
    P516-0475
    		Inhibitor
    P516-0475 is an uncompetitive inhibitor against endopeptidase PepO. P516-0475 is also an agonist of the Rgg2/3 system with antibacterial activity. P516-0475 induces expression of Rgg2/3-regulated genes in the presence of short hydrophobic pheromone (SHP) for activity and leads to positive modulation of lysozyme resistance.
    P516-0475
  • HY-N10479
    Chorismic acid
    Chorismic acid is a precursor for the biosynthesis of aromatic amino acids and vitamins, as well as a key metabolite in tRNA modification. Chorismic acid is a critical metabolite for the synthesis of cmo5U. Deficiency of Chorismic acid inhibits the formation of cmo5U and mcmo5U. Chorismic acid can be used in studies of S. typhimurium and E. coli infections.\n
    Chorismic acid
  • HY-B0108AS
    Daptomycin-d5
    		Inhibitor
    Daptomycin-d5 (LY146032-d5) is the deuterium labeled Daptomycin (HY-B0108). Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.
    Daptomycin-d<sub>5</sub>
  • HY-N19219
    Wailupemycin F
    		Inhibitor
    Wailupemycin F is an Antibiotic and anticancer agent. Wailupemycin F is isolated from the marine-derived Streptomyces maritimus. Wailupemycin F exhibits antibacterial activity against Micrococcus luteus with a MIC of 1.1 μM. Wailupemycin F shows anticancer activity against myeloma. When used in combination with enterocin, Wailupemycin F exerts synergistic antibacterial activity against Micrococcus luteus, doubling its potency. Wailupemycin F can be used in studies related to Micrococcus luteus infection.
    Wailupemycin F
  • HY-N14891
    Pristinamycin ⅠC
    		Inhibitor
    Pristinamycin IC is an ester peptide antibiotic with anti-Gram-positive bacteria effects.
    Pristinamycin ⅠC
  • HY-W042181R
    N-Decyl-N,N-dimethyldecan-1-aminium chloride (Standard)
    		Inhibitor
    N-Decyl-N,N-dimethyldecan-1-aminium (chloride) (Standard) is the analytical standard of N-Decyl-N,N-dimethyldecan-1-aminium (chloride). This product is intended for research and analytical applications. N-Decyl-N,N-dimethyldecan-1-aminium chloride (Didecyldimethylammonium chloride) is a dialkyl-quaternary ammonium compound that is used in numerous products for its bactericidal, virucidal and fungicidal properties.
    N-Decyl-N,N-dimethyldecan-1-aminium chloride (Standard)
  • HY-182488
    Pulvinamide
    		Inhibitor
    Pulvinamide is a tetronic acid pigment, a pulvinic acid derivative, an Antibacterial agent and Antifungal agent. Pulvinamide can be isolated from lichens. Pulvinamide weakly inhibits the growth of Bacillus subtilis (ATCC 6633) with an MIC of 50 μg/mL. Pulvinamide weakly inhibits the growth of Candida albicans (ATCC 10231) and Saccharomyces cerevisiae (ATCC 9763), with MIC values of 200 μg/mL and 100 μg/mL, respectively.
    Pulvinamide
  • HY-N0656R
    Usnic acid (Standard)
    		Inhibitor
    Usnic acid is a secondary metabolite of lichens with a unique dibenzofuran skeleton. Usnic acid inhibits DNA/RNA synthesis and has antibacterial activity. Usnic acid induces cell cycle arrest and apoptosis and has anticancer activity. Usnic acid inhibits RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1. Usnic acid has antioxidant and anti-inflammatory activities by inhibiting lipid peroxidation and myeloperoxidase.
    Usnic acid (Standard)
  • HY-N14342
    Manumycin E
    		Inhibitor
    Manumycin E has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin E inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin E
  • HY-13832R
    Atovaquone (Standard)
    Atovaquone (Standard) is the analytical standard of Atovaquone. This product is intended for research and analytical applications. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex. Atovaquone is against human and  P. falciparum cytochrome bc1 activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia.
    Atovaquone (Standard)
  • HY-W343592
    3-Aminoisonicotinohydrazide
    		Inhibitor
    3-Aminoisonicotinohydrazide is an anti-bacterial agent. 3-Aminoisonicotinohydrazide exhibits inhibitory activity against Mycobacterium tuberculosis. 3-Aminoisonicotinohydrazide can be used in antibacterial research.
    3-Aminoisonicotinohydrazide
  • HY-N5174
    Azetomycin II
    		Inhibitor
    Azetomycin II (Azet-II) has the effect of anti-Gram positive bacteria.
    Azetomycin II
  • HY-178436
    Antituberculosis agent-16
    		Inhibitor
    Antituberculosis agent-16 is an orally active antituberculosis agent. Antituberculosis agent-16 exhibits stable antituberculosis activity with a MIC of 0.48 μg/mL against Mycobacterium tuberculosis H37Rv sensitive strain and 0.49 μg/mL against multidrug-resistant strain 14862. Antituberculosis agent-16 shows high Caco-2 permeability. Antituberculosis agent-16 can be used for the research of infection.
    Antituberculosis agent-16
Cat. No. Product Name / Synonyms Application Reactivity